These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12762348)

  • 41. Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate.
    Todd G; Dunlop K; McNaboe J; Ryan MF; Carson D; Shields MD
    Lancet; 1996 Jul; 348(9019):27-9. PubMed ID: 8691927
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparison of fluticasone propionate 200 micrograms/day with beclomethasone dipropionate 400 micrograms/day in adult asthma.
    Leblanc P; Mink S; Keistinen T; Saarelainen PA; Ringdal N; Payne SL
    Allergy; 1994 May; 49(5):380-5. PubMed ID: 8092438
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part II. Safety aspects of therapy with fluticasone propionate in asthmatic children].
    Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
    Pol Merkur Lekarski; 2004; 17 Suppl 2():11-8. PubMed ID: 15688664
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ciclesonide, a novel inhaled steroid, does not affect hypothalamic-pituitary-adrenal axis function in patients with moderate-to-severe persistent asthma.
    Szefler S; Rohatagi S; Williams J; Lloyd M; Kundu S; Banerji D
    Chest; 2005 Sep; 128(3):1104-14. PubMed ID: 16162694
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [TBL] [Abstract][Full Text] [Related]  

  • 46. No effect of fluticasone propionate on linear growth in preschool children with asthma.
    Stefanovic IM; Verona E; Cicak B; Vrsalovic R
    Pediatr Int; 2011 Oct; 53(5):672-676. PubMed ID: 21342354
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma.
    Nelson HS; Busse WW; deBoisblanc BP; Berger WE; Noonan MJ; Webb DR; Wolford JP; Mahajan PS; Hamedani AG; Shah T; Harding SM
    J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):267-75. PubMed ID: 9949318
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fluticasone propionate in children with moderate asthma.
    Hoekstra MO; Grol MH; Bouman K; Stijnen T; Köeter GH; Kauffman HF; Gerritsen J
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1039-44. PubMed ID: 8887604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 24 hour and fractionated profiles of adrenocortical activity in asthmatic patients receiving inhaled and intranasal corticosteroids.
    Wilson AM; Lipworth BJ
    Thorax; 1999 Jan; 54(1):20-6. PubMed ID: 10343626
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systemic exposure and urinary cortisol effects of fluticasone propionate formulated with hydrofluoroalkane in 4- to 11-year-olds with asthma.
    Kim KT; Milgrom H; Yoon YK; Levy AL; Matz P; Welch MJ; Cahn A; Collins DA; Kathman S; Mehta R; Su SF; Kunka RL
    J Clin Pharmacol; 2008 Jan; 48(1):108-16. PubMed ID: 18094223
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic index of inhaled corticosteroids in asthma: A dose-response comparison on airway hyperresponsiveness and adrenal axis suppression.
    Daley-Yates P; Brealey N; Thomas S; Austin D; Shabbir S; Harrison T; Singh D; Barnes N
    Br J Clin Pharmacol; 2021 Feb; 87(2):483-493. PubMed ID: 32484940
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adrenal suppression with dry powder formulations of fluticasone propionate and mometasone furoate.
    Fardon TC; Lee DK; Haggart K; McFarlane LC; Lipworth BJ
    Am J Respir Crit Care Med; 2004 Nov; 170(9):960-6. PubMed ID: 15184207
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function.
    Sheth KK; Cook CK; Philpot EE; Prillaman BA; Witham LA; Faris MA; Klein KC; Rickard KA
    Allergy Asthma Proc; 2004; 25(2):115-20. PubMed ID: 15176496
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Asthma and Cushing's syndrome.
    Wilson AM; Blumsohn A; Jung RT; Lipworth BJ
    Chest; 2000 Feb; 117(2):593-4. PubMed ID: 10669710
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review.
    Dyer MJ; Halpin DM; Stein K
    BMC Fam Pract; 2006 Jun; 7():34. PubMed ID: 16753053
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fluticasone propionate versus zafirlukast: effect in patients previously receiving inhaled corticosteroid therapy.
    Kim KT; Ginchansky EJ; Friedman BF; Srebro S; Pepsin PJ; Edwards L; Stanford RH; Rickard K
    Ann Allergy Asthma Immunol; 2000 Nov; 85(5):398-406. PubMed ID: 11101185
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and fluticasone propionate in patients with persistent asthma.
    Xu J; Nave R; Lahu G; Derom E; Derendorf H
    J Clin Pharmacol; 2010 Oct; 50(10):1118-27. PubMed ID: 20150524
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The comparison of the effects of fluticasone propionate and budesonide on clinical indices and on bone mineral density in the asthmatic patients: a one year treatment study.
    Harmanci E; Ak I; Ozdemir N; Vardareli E; Elbek O; Uçgun I
    Allergol Immunopathol (Madr); 1999; 27(6):298-303. PubMed ID: 10611554
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients.
    Ringdal N; Lundbäck B; Alton M; Rak S; Eivindson A; Bratten G; Kjaersgaard P
    Respir Med; 2000 May; 94(5):482-9. PubMed ID: 10868712
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Osteocalcin, cortisol levels, and bone mineral density in prepubertal children with asthma treated with long-term fluticasone propionate.
    Ozkaya E; Nursoy MA; Uzuner S; Erenberk U; Çakır E
    Horm Res Paediatr; 2012; 77(6):351-7. PubMed ID: 22760032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.